Downloadable PDF reviewing FDA-approved therapies and testing strategies for clinically relevant BRAF mutations in multiple solid tumors.
Downloadable PDF covering genetic risk, therapies, and testing strategies for BRCA1/2 mutations in breast, ovarian, pancreatic, and prostate cancers.
Download this free slideset by Michael J. Pishvaian, MD, Ph for a brief overview of the current use of BRCA mutation status to identify patients with select tumor types for treatment with PARP inhibitors.
Download this free slideset by Axel Grothey, MD, for a brief overview of the optimal treatment options for patients with cancer and BRAF, MAPK, or HER2 alterations.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.